Search research articles
Contact Us
Filters
Showing results (111-120 of 115) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 115 results.
Journal of Virology
|
March 1, 1993
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody
T J Smith, N H Olson, R H Cheng, et al.
Journal of Virology
|
July 10, 1999
Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity
R McKenna, N H Olson, P R Chipman, et al.
Nature
|
December 29, 2000
Structure of the bacteriophage phi29 DNA packaging motor
A A Simpson, Y Tao, P G Leiman, et al.
Cancer Research
|
November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose
A C van Hof, C F Molthoff, Q Davies, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01
H M Prinssen, C F Molthoff, R H Verheijen, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 115) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 115 results.
Journal of Virology
|
March 1, 1993
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody
T J Smith, N H Olson, R H Cheng, et al.
Journal of Virology
|
July 10, 1999
Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity
R McKenna, N H Olson, P R Chipman, et al.
Nature
|
December 29, 2000
Structure of the bacteriophage phi29 DNA packaging motor
A A Simpson, Y Tao, P G Leiman, et al.
Cancer Research
|
November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose
A C van Hof, C F Molthoff, Q Davies, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01
H M Prinssen, C F Molthoff, R H Verheijen, et al.
Page
of 12